Silo Pharma, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-4.2M | $-4.4M | $-3.7M | $-3.9M | $3.9M | $-3.0M | $-1.0M | $-969.5K |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | $11.4K | $6.2K | — | — | — | — | $0 | $17.6K |
| Stock-Based Compensation | $117.0K | $906.8K | $871.6K | $577.7K | $395.1K | $756.0K | $319.6K | $145.0K |
| Net Cash from Operating Activities | $-4.7M | $-3.8M | $-3.2M | $-3.5M | $-2.3M | $-1.2M | $-794.3K | $272.6K |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $644.0K | $973.8K | $-4.1M | $86.7K | $7.2M | $39.0K | $186.7K | $-250.0K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $4.9M | $3.2M | $-471.1K | $4.9M | $3.8M | $2.1M | $382.7K | $19.5K |
| Net Change in Cash | — | — | — | — | — | — | $-224.9K | $42.1K |
| Free Cash Flow | — | — | — | — | — | — | — | — |